Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New immune checkpoint antibody AbGn-168H displays promising efficacy and is well tolerated

Nov. 12, 2020

Corbus reports post-hoc analyses of RESOLVE-1 study of lenabasum for systemic sclerosis

Nov. 11, 2020

Promising phase II data for deucravacitinib in active psoriatic arthritis

Nov. 11, 2020

First-in-human data for LNA-043 as treatment of knee osteoarthritis

Nov. 11, 2020

SHR-0302 displays dose-dependent effects in rheumatoid arthritis

Nov. 11, 2020

Active pipeline of potential new lupus therapies unfolding as ACR begins

Nov. 6, 2020

Macrophages metabolically support muscle

Nov. 5, 2020

Discovery of novel highly potent ghrelin receptor full agonists

Oct. 20, 2020

Phase II trial of GLPG-1972 in osteoarthritis does not meet primary objective

Oct. 16, 2020

Ono Pharmaceutical synthesizes bispecific antibodies targeting CD19 and PD-1

Oct. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Beone eyes Huahui Health’s trispecific HH-160 with $2B option deal
BioWorld
Beone Medicines Ltd. gained an exclusive option to develop cancer immunotherapy HH-160 worldwide in a deal potentially worth more than $2 billion for Huahui...
Unique trial strategy muddies the ODAC waters for camizestrant
BioWorld
Following a discussion that focused more on a new personalized trial strategy rather than the proposed therapy, the U.S. FDA’s Oncologic Drugs Advisory Committee...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...